| Literature DB >> 29040604 |
Varghese George1, Linda Harrison2, Margaret Roach1, Xiao-Dong Li3, Camlin Tierney2, Margaret A Fischl4, Judith Aberg5, Pablo Tebas6, David M Asmuth3, Richard B Pollard3, Catherine Godfrey7, Savita Pahwa1.
Abstract
A nested case-cohort study was performed in participants of a clinical trial of first-line human immunodeficiency virus treatments to investigate plasma biomarkers of inflammation and microbial translocation for their association with immune reconstitution inflammatory syndrome (IRIS). Fifty-one of 1452 participants with baseline CD4 count <350 cells/μL developed IRIS. Plasma from 51 IRIS cases, including 6 stratified by preenrollment CD4 count ≤200 cells/μL, were analyzed and compared to 94 non-IRIS controls. At baseline, CXCL10, lipopolysaccharide, soluble CD14, 16S ribosomal DNA, and interferon-α2 were associated with greater risk of IRIS. Systemic inflammation through persistent monocyte activation and microbial translocation appear to be important in IRIS pathogenesis.Entities:
Keywords: IRIS; cytokines; immune reconstitution inflammatory syndrome; microbial translocation
Mesh:
Substances:
Year: 2017 PMID: 29040604 PMCID: PMC5853564 DOI: 10.1093/infdis/jix460
Source DB: PubMed Journal: J Infect Dis ISSN: 0022-1899 Impact factor: 5.226